This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX USA Congress
Connecting Innovators with Strategic Knowledge & Capital
September 16th - 17th, 2025Boston Convention and Exhibition Center, MA, USA
Book Now
Menu
Book Now
Key Sessions
Simone Mori
Globalization to Deliver Comprehensive Early Clinical Data to Mitigate the Current Biotech Investment Benchmarks
Moderna
Luba Greenwood
The CVC Perspective: Strategic Venturing in Biotech Throughout 2024 & Beyond
Dana-Farber Cancer Institute
Maha Radhakrishnan
Revolutionizing the Future: Unveiling the Dynamics of Biotech Investment and Deals in the USA
Sofinnova Investments
Michelle Li
Pharma Fusion: Spearheading Growth Through M&A and Partnering in 2024
Bristol Myers Squibb
Tadaaki Taniguchi
Pharma Keynote: Pioneering Partnerships: Building Alliances that Push the Boundaries of Science in Underserved Diseases
Astellas Pharma
Hong Chen
The Pill-ar of Success: Navigating Pharma Collaborations and Spotting Innovation
Novo Nordisk
keyboard_arrow_right

Day 1 – Wednesday, 11 SEPTEMBER - ET (Eastern Time, GMT-05:00)

keyboard_arrow_leftSearch & Filter
search
Day 1 – Wednesday, 11 SEPTEMBER - ET (Eastern Time, GMT-05:00)
search
8:00am - 9:00am
Registration & Breakfast
Showing 3 of 3 Streams
9:00am - 9:05am
LSX Welcome Address
  • Adam Griffiths - Senior Director, Biotech Lead, Informa
9:05am - 9:30am
Assessing Biotech Investment Trends in 2024 and Beyond
  • Cody Powers - Partner, ZS Associates
9:30am - 10:10am
Revolutionizing the Future: Unveiling the Dynamics of Biotech Investment and Deals in the USA
  • Maha Radhakrishnan - Executive Partner, Sofinnova Investments
  • Chris Jeffers - SVP, Life Sciences, Brown Rudnick
  • Jim MacKrell - VP Lilly Venture Science, Eli Lilly
  • Issi Rozen - General Partner, Google Ventures
  • Richard Kivel - CEO, Graybella Capital
  • Bibhash Mukhopadhyay - Managing Partner & Co-Founder, Sound Bioventures
10:10am - 10:30am
Pharma Keynote: Pioneering Partnerships: Building Alliances that Push the Boundaries of Science in Underserved Diseases
  • Tadaaki Taniguchi - Chief Medical Officer, Astellas Pharma
  • Christina Corridon - Managing Principal, ZS
10:30am - 11:00am
Morning Break
9:00am - 9:10am
LSX Welcome Address
  • Jack Giles - Conference Producer, LSX
9:10am - 9:50am
Sustained Success - A Holistic Review of MedTech in 2024
  • Marissa Fayer - CEO, DeepLook Medical
  • Carla Peron - Chief Medical Officer, Philips
  • Joseph Smith - CSO, BD
  • Mahala Burn - VP, Corporate Development, bioMérieux
  • Brian Montgomery - Chief Strategy Officer, GE HealthCare
9:50am - 10:30am
Promises in Pixels - Evaluating AI's Impactful Delivery
  • Jeff Chu - Managing Partner, Features Capital
  • Susan Wood - CEO, Vida Diagnostics
  • Karen Holzberger - President & CEO, SpinTech MRI
  • Chris Ciriello - CEO & Co-Founder, Perceptive
  • Sanjay Parekh - Global Strategy Business Development, Perspectum
10:30am - 11:00am
Morning Break
9:00am - 9:10am
LSX Welcome Address
  • Nadia Konneh - Senior Conference Director, Healthtech Lead, LSX
9:10am - 9:50am
Defining our AI Future – Operationalising AI to Deliver Business & Patient Benefits
  • Ziv Bar-Joseph - VP, Head, R&D Data & Computational Sciences, Sanofi
  • Amir Zur - Former Executive Director, Head of R&D Digital Head Products, Takeda
  • Shweta Maniar - Global Director Health & Life Sciences, Google
  • Antonio Regalado - Biomedicine Editor, MIT Technology Review
  • Jane Yan - COO & Chief Product Officer, LunaJoy Health
  • Kaushik Gune - President, EVP, Huma US
9:50am - 10:30am
DTx 2.0 – Building the Right Digital Therapeutic Business Model for Long-Term Growth & Revenue
  • Joe Perekupka - CEO, Freespira
  • David Klein - CEO, Click Therapeutics
  • Andy Molnar - CEO, Digital Therapeutics Alliance
  • Adam Pellegrini - CEO, Kaia Health
10:30am - 11:00am
Morning Break
Showing 5 of 5 Streams
11:00am - 11:40am
The Venture Investor Outlook and Investing in the Therapies of Tomorrow
  • Jeff Quillen - Partner, Foley Hoag
  • Dirk Landgraf - Partner, SV Health Investors
  • Evan Caplan - Principal, OrbiMed
  • Eric Snyder - Partner, Venture Investments, Novo Holdings
  • Rebecca Luse - Principal, Deep Track Capital
  • Ralf Saykiewicz - Managing Partner, Raudi Capital
11:40am - 12:00pm
Globalization to Deliver Comprehensive Early Clinical Data to Mitigate the Current Biotech Investment Benchmarks
  • Simone Mori - Head, External Research Venture, Moderna
  • Chris Hickey - CBO, Nucleus Networks
  • Kiran Reddy - Senior Managing Director, Blackstone LIfe Sciences
  • Biljana Georgievska - CCO, Nucleus Networks
12:00pm - 12:40pm
Understanding Shifts in Early-Stage VC Investment Criteria
  • Lynn Lewis - Founder & CEO, Gilmartin Group
  • Stephen Bruso - Partner, Morningside Advisory
  • John Boyce - Managing Director & Co-Founder, TigerGene
  • Reetika Bhardwaj - Senior Associate, ARCH Venture Partners
11:00am - 11:40am
The Pill-ar of Success: Navigating Pharma Collaborations and Spotting Innovation
  • Hong Chen - Director, Search & Evaluation USA, Novo Nordisk
  • Hannah England - Partner, Ropes & Gray
  • Mankit Law - Director - BD, Search & Evaluation, GSK
  • Jeremy O’Hanlon - Executive Director, Global BD, Daiichi-Sankyo
  • Greg Fralish - CBO, GlycoEra
11:40am - 12:00pm
Partnering Globally: Enabling Different Strategies and Approaches to Drive Innovation
  • Andrew Whittle - Director, BD&L, Boehringer Ingelheim
12:00pm - 12:40pm
Driving Innovation in Life Sciences Through Fostering Strong Partnerships Between Industry, Academia, and NPOs
  • Alison Fenney - Executive Director, Strategic Partnerships and Business Operations, Regeneron Genetics Center
  • Alfred Slanetz - Chairman, National Foundation for Cancer Research
  • James Zanewicz - Chief Strategy Officer, Tulane University
  • Peter Meinke - Sanders Director, Tri-Institutional Therapeutics Discovery Institute
  • Jukka Muhonen - President, AllianceXConsulting
11:00am - 11:40am
Funding Biotech Innovation and Scaling Up
  • Kyle DiLella - Team Lead, Emerging Corporate Life Sciences, Citibank
  • Ellen Donnelly - CEO, Abliva
  • Ann Belien - CEO & Founder, Rejuvenate Biomed
  • Daniel Janse - CEO, AffyImmune
  • Dan Passeri - CEO, Cue Biopharma
  • Rachel Ravens - CEO, 42Genetics
11:40am - 12:00pm
Accelerating Cures: Speeding Up Clinical Trials to Maximize Returns For All
  • Ben van der Schaaf - Partner, Arthur D. Little
  • Ben Enejo - Partner, Arthur D. Little
12:00pm - 12:40pm
Integrating CMC Development for Value Creation in Biotech Start-Ups
  • Zeid Barakat - Partner, Scimitar
  • Johannes Roebers - Head of Business Development Unit, ProductLife Group
  • Dan Jacobs - VP, CMC Operations, Flagship Pioneering
  • Chase Orsello - Global Head Bioprocess Development, Sanofi
  • Neera Jain - Vice President, Chemical Pharmaceutical Development & Operations, Syros Pharmaceuticals
  • Federico Pollano - SVP, Business Development, Rentschler
11:00am - 11:50am
Keeping The Cash Flow - Sustaining Momentum Through Maturation
  • Rowan Walrath - Life Sciences Reporter, C&EN, American Chemical Society
  • Darshana Zaveri - Managing Partner, Catalyst Health Ventures
  • Karthik Bolisetty - Senior Associate, Gilde Healthcare
  • Jed Cohen - Managing Director, Medical Technology Investment Banking, Raymond James
  • Sean Cheng - Managing Director, Ascension Ventures
11:50am - 12:40pm
Rulebooks & Revenue - Winning Strategies For US Medtech Compliance & Market Access
  • Julie Lankiewicz - Director, Global Clinical Strategy - Orthopaedics, Robotics and Digital Health/Enabling Technologies, Smith+Nephew
  • Karen Cross - Co-Founder & CEO, MIMOSA Diagnostics
  • John Konsin - CEO & Co-Founder, Prapela
  • Christy Sheehy-Bensinger - CEO & Founder, C-Light Technologies
  • Shaherah Yancy - CEO & Founder, Research Lifecycle Solutions
  • Giles Hamilton - Operating Partner, New Growth Advisors
11:00am - 11:50am
Streamlining Clinical Trials for Patients & Clinicians Through Digital
  • John Wagner - Chief Medical Officer, Koneksa
  • Jodi Akin - Founding CEO, Hawthorne Effect
  • Sarah Valentine - Partnerships Lead, Life Sciences, Digital Medicine Society (DiMe)
  • Ben Casavant - Co-Founder & CEO, Tasso
  • Ritesh Patel - Senior Director, Global Digital Health, FINN Partners
11:50am - 12:40pm
Overcoming Pharma & Medtech’s Digital Transformation Challenges – How to Change for Real?
  • Saurav Gupta - Senior Director, Platform Strategy & Implementation – Connected Care, Eli Lilly
  • Nishtha Jain - Head of Innovation & Digital Technology, Takeda
  • Kevin McRaith - President & CEO, Welldoc
  • Jonah Comstock - Editor in Chief, pharmaphorum
12:40pm - 1:40pm
Lunch Break
Showing 5 of 5 Streams
1:40pm - 2:30pm
Building Strong Biotech Foundations: Governance, Growth, and Fundraising Strategies
  • Doug Locke - CEO, SSI Strategy
  • Madhav Gurijala - SVP Business Consulting, SSI Strategy
  • Steve Zelenkofske - Executive Advisor, SLZ Consulting
  • Björn Cochlovius - CEO, eleva
2:30pm - 3:20pm
The CVC Perspective: Strategic Venturing in Biotech Throughout 2024 & Beyond
  • Luba Greenwood - Managing Partner, Binney Street Capital Venture Fund, Dana-Farber Cancer Institute
  • Marian Nakada - VP, Venture Investments, JJDC
  • Aaron Nelson - Managing Director, Novartis Venture Fund
  • Fei Shen - Managing Director, Boehringer Ingelheim Venture Fund
  • Irena Melnikova - Partner, Pfizer Ventures
1:40pm - 2:30pm
The Oncology Odyssey: Exploring New Market Trends In Cancer Research and Partnering
  • Alex Philippidis - Senior Business Editor, Genetic Engineering & Biotechnology News
  • Natalia Ulyanova - Business Development Director, Oncology, Astellas, USA
  • William Ho - President & CEO, IN8bio
  • Elizabeth Wood - Founder & CEO, JURA Bio
  • José Mejía Oneto - CEO, Shasqi
  • Tim Sullivan - CBO, Infinimmune
2:30pm - 3:20pm
Key Stakeholders in Building a Robust Women’s Health Ecosystem
  • Anula Jayasuriya - Co-Founder, Kidron Capital
  • Elizabeth Garner - President, KNI Health Consultants
  • Elizabeth Bailey - Managing Director, RH Capital
  • Lori Frank - President, WHAM
  • Allison Watkins - Founder & CEO, Watkins-Conti Products, Inc
  • Gerardo Toledo - CEO & Co-founder, Solarea Bio
1:40pm - 2:30pm
Commercialization Strategies for Biotechs and Early-Planning
  • Joe Goldberg - Partner, RSM US LLP
  • Dan Oliver - CEO, Rejuvenate Bio
  • Michelle Chen - CBO, Insilico Medicine
  • Jeff Landau - CBO, CytomX
  • Sohail Zaidi - CEO, Ananda Scientific
2:30pm - 3:20pm
Developing an Effective Message and Strategic Positioning in a Crowded Market
  • David Brower - CBO, Accent Therapeutics
  • Jae Won Kim - COO & CFO, VantAI
  • Kimberly Ha - Founder & CEO, KKH Advisors
  • Michael Goldberg - CEO, Surge Therapeutics
  • Regina Salvat - Principal, Sofinnova Investments
1:40pm - 2:30pm
Ctrl+Challenge – SaaMD Pathways and Pitfalls
  • Sheena Dempsey - Chief Solutions Officer, Indivi
  • Cathy Skinner - CEO, NXgenPort Inc
  • Kevin Stevens - Head, Global Regulatory Affairs Device, PDT, Takeda
  • Arvind Ramadorai - Global Head of Innovation, Robotic Surgery Technologies, Medtronic
  • Shruti Choudhary - SVP, Product, Elucid
2:30pm - 3:20pm
Access Granted - Strategies For Successful Market Entry
  • Christine Horton - CEO, Visura Technologies
  • Nishant Doctor - CEO, Surf Therapeutics
  • Marc Jones - CEO, Altoida
  • Kristen Hedstrom - VP, Market Access & Professional Education, Integra LifeSciences
  • Ryan McGuinness - Commercial General Manager, Triple Ring Technologies
1:40pm - 2:30pm
Healthtech Business Scale Up - Setting Healthtech Companies up for Success
  • Sam Oddson - Chief Medical Officer, Sidekick Health
  • Patricia Bradley - Global CCO, MindMaze
  • Katerina Fialkovskaya - Venture Investor, Philips Ventures
  • Yasir Drabu - Founder & CEO, Taazaa
  • Gemma Wenstrom - COO, Kaia Health
  • Sunnie Southern - Founder & CEO, Viable Synergy
2:30pm - 3:20pm
Building Sustainable, Value-Based Strategic Digital Health Partnerships
  • Catherine Blanchette - VP & Head of Digital Strategic Partnerships, Sanofi
  • Ameya Phadke - Patients Non-Pharma Solutions Leader, Chiesi
  • Nathan Sundheimer - Former Head, US Healthcare Partnerships, Plug and Play
  • Jin Lee - Founder & CEO, IMIDeology
  • Abhay Kakde - Director, Global Strategy & Operations, AstraZeneca
3:20pm - 3:50pm
Afternoon Break
Showing 3 of 3 Streams
3:50pm - 4:30pm
Maximizing Returns: Unleashing the Power of AI for Tangible ROI
  • Mark Stead - Head of BD, Atomic AI
  • Greg Ryslik - CTO, COMPASS Pathways
  • Elizabeth Schwarzbach - CBO, BigHat Biosciences
  • Ben Hohn - Principal, BD, Pipeline and Launch Strategy, ZS Associates
  • Kfir Schreiber - CO-founder & CEO, DeepCure
4:30pm - 4:50pm
Forging Alliances and Leveraging Acquisitions to Generate Shared Value for Patients, People, Communities, the Planet and Thriving as Business
  • Stefano Cottignoli - Head of Global Business and Corporate Development, Chiesi Group
4:50pm - 5:00pm
Biopharma Partnering Benchmarking Report
  • Michael Rai - General Manager, partneringONE
  • Millie Nelson - Editor, BioXconomy, Informa Connect Life Sciences
5:00pm - 5:40pm
Pharma Fusion: Spearheading Growth Through M&A and Partnering in 2024
  • Michelle Li - Vice President and Head, BD&L Transactions, Bristol Myers Squibb
  • Nicole Daley - Partner, A&O Shearman
  • Philippe Lopes-Fernandes - EVP, CBO, Ipsen
  • Dave Moore - EVP, Coporate Development, Novo Nordisk
  • Sarah Kilpatrick - VP Business Development, Pfizer
  • Issei Tsukamoto - SVP, Global Head Business Development, Astellas
3:50pm - 4:40pm
Strategic Synergies: Scaling Through Industry Collaboration
  • JoJo Platt - Senior Contributing Editor, Neurotech Reports
  • Kurt Haggstrom - CCO, Synchron
  • Ana Maria Maiques Valls - CEO, Neuroelectrics
  • Anh Hoang - CEO, Jana Care
  • Jonathan Hoyt - Executive Director, Global Market Development, Olympus Corporation of the Americas
4:40pm - 5:30pm
Put It On Your Pitchdeck - Meeting Investor Expectations
  • Michael Bison - Partner, Goodwin
  • Scott Gazelle - Co-Founder & Managing Partner, GreyBird Ventures
  • Amy Salzhauer - Founder & Managing Partner, Good Growth Capital
  • Eddie Hanlon - Investment Manager, Gilde Healthcare
  • Jotthe Kannappan - Senior Associate, Intuitive Ventures
3:50pm - 4:40pm
AI Forward- Pursuing the Safe, Responsible and Meaningful Integration of Generative AI in Healthcare
  • Neil Sahota - CEO, ACSI Labs & AI Advisor, United Nations
  • Dale Cyr - CEO & Executive Director, Inteleos
  • Sheila Phicil - Director of Innovation, Boston Medical Center Health System
  • Julie O'Shaughnessy - COO, Vivodyne
4:40pm - 5:30pm
Time for Revival? Healthtech & Digital Health Investment
  • Jonathan Machado - Managing Director, Samsung NEXT
  • Tunde Akinniranye - Investor, 7wire Ventures
  • Ian Chiang - Partner, Flare Capital
  • Cheryl Cheng - Founder & CEO, Vive Collective
  • Austin Poole - Partner, BIP Ventures
5:40pm - 5:45pm
Close Of Day One Agenda – Drinks Reception
Forums and Workshop (September 12)
NextDay 2 – Thursday, 12 SEPTEMBER
Filter
Streams
Formats
Choose Day